NewsSource: EClinCloud official website historical archive

Good News | EClinCloud Wins Industry First Prize at the Innovation Nanshan 2022 "Entrepreneurship Star" Competition

2 min readEClinCloud Editorial Team
Good News | EClinCloud Wins Industry First Prize at the 2022 Innovation Nanshan "Entrepreneurship Star" Competition (archived article cover)

 

On December 12, the Innovation Nanshan 2022 "Entrepreneurship Star" Competition grand finals concluded. On December 13, the awards ceremony was held in Nanshan District, Shenzhen. The "EClinCloud Remote Intelligent Clinical Research Cloud Platform" project won First Prize in the Growth Enterprise Group of the Electronic Information Industry.

 

2022创业之星电子信息行业成长企业组一等奖图示  

 

创新南山2022创业之星大赛海报  

Guiding Organizations:

China Association for Science and Technology and Shenzhen Municipal People's Government

Organizers:

People's Government of Nanshan District, Shenzhen; Science, Technology and Innovation Commission of Shenzhen Municipality; and Shenzhen Association for Science and Technology

Organizer:

Shenzhen Nanshan District Science and Technology Innovation Bureau (Association for Science and Technology)

 

创新南山2022创业之星大赛颁奖现场  

Huang Xiangyue, Deputy Secretary of the Shenzhen Nanshan District Committee and District Mayor, attended the event and noted in his remarks that the "Entrepreneurship Star" Competition has been held for 15 consecutive years and has become a well-known competition brand connecting global innovation and entrepreneurship resources in Nanshan District, Shenzhen—resources that serve as the wellspring of Nanshan's enduring vitality and upward growth. Going forward, Nanshan District will make every effort to build a world-class business environment, bring together more innovative enterprises, institutions, and talent from home and abroad, and continuously strengthen the leading power, hard power, driving force, supporting capacity, and foundational momentum of Nanshan's innovation.

 

创新南山2022创业之星颁奖典礼照片  

The competition drew more than 600 registered projects. Spanning half a year, through intense competition across the preliminary, semifinal, and final rounds in six industry tracks, 20 projects stood out and advanced to the grand finals, and EClinCloud was one of them.

 

Ultimately, the "EClinCloud Remote Intelligent Clinical Research Cloud Platform" project won First Prize in the Growth Enterprise Group of the Electronic Information Industry. This is recognition from numerous expert judges of EClinCloud's technical capabilities, business model, and market potential, as well as strong evidence of EClinCloud's standing as an enterprise with core strengths in the next-generation information technology field.

 

In the future, EClinCloud will continue to rely on its integrated clinical evidence support SaaS cloud platform, deepen its focus in the field of digital clinical trial solutions, uphold its mission of "bringing effective treatments to patients through technological innovation," and help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs/devices, and benefit countless patients.


About EClinCloud

EClinCloud is a technology company focused on clinical research and development, providing an integrated, interconnected, all-in-one cloud platform for clinical trials (including CTMS, eTMF, EDC, RTSM, and eCOA, among other technology products, and scale management, linguistic validation, rater training, and data quality analysis, among other solutions) as well as clinical trial endpoint assessment technologies across different therapeutic areas (including oncology, central nervous system, and ophthalmology, among others), combining cutting-edge technology with life data to build a world-leading "patient-centric" SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs/devices, and benefit countless patients.

 

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.